March 5, 2018 / 9:30 PM / 3 months ago

BRIEF-Opiant Pharma Says Teva Filed ANDA With FDA For Marketing Approval Of Generic Version Of Narcan 2 Mg/Spray

March 5 (Reuters) - Opiant Pharmaceuticals Inc:

* OPIANT PHARMACEUTICALS SAYS ON FEB 27, CO AND ADAPT PHARMA OPERATIONS LIMITED RECEIVED NOTICE FROM TEVA PHARMACEUTICALS USA INC - SEC FILING

* OPIANT PHARMACEUTICALS - TEVA FILED ANDA WITH FDA FOR MARKETING APPROVAL OF GENERIC VERSION OF NARCAN 2 MG/SPRAY NASAL SPRAY BEFORE EXPIRY OF CERTAIN U.S. PATENTS Source text: (bit.ly/2I5daXC) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below